Guizhou Bailing Group Pharmaceutical Co., Ltd.
public_traded
Guizhou Bailing Group Pharmaceutical Co., Ltd. is publicly traded on SHZ under ticker 002424.SZ.
Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 2005 and is based in Anshun, China.